Inhibition of nitric oxide synthase induction by 15-deoxyspergualin in a cultured macrophage cell line, J744A.1 activated with IFN-γ and LPS

Journal of Antibiotics

Volumn 52, Issue 3, 1999, Pages 297-304

  Nosaka, Chisato ^a   Kunimoto, Setsuko ^a   Atsumi, Sonoko ^a   Takeuchi, Tomio ^a  

^a INSTITUTE OF MICROBIAL CHEMISTRY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXYSPERGUALIN; GAMMA INTERFERON; IMMUNOSUPPRESSIVE AGENT; LIPOPOLYSACCHARIDE; N 30; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL STIMULATION; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

EID: 0032903575     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.52.297     Document Type: Article

References (31)

1. IWASAWA, H.; S. KONDO, D. IKEDA, T. TAKEUCHI & H. UMEZAWA: Synthesis of (15)-deoxyspergualin and (-)-spergualin-15-phosphate. J. Antibiotics 35: 1665-1669, 1982
2. TAKEUCHI, T.; H. IINUMA, S. KUNIMOTO, T. MASUDA, M. ISHIZUKA, M. TAKEUCHI, M. HAMADA, H. NAGANAWA, S. KONDO & H. UMEZAWA: A new antitumor antibiotic, spergualin. Isolation and antitumor activity. J. Antibiotics 34: 1619-1621, 1981
3. MASUDA, T.; S. MIZUTANI, M. IIJIMA, H. ODAI, H. SUDA, M. ISHIZUKA, T. TAKEUCHI & H. UMEZAWA: Immunosuppressive activity of 15-deoxyspergualin and its effect on skin alografts in rats. J. Antibiotics 40: 1612-1618, 1987
4. NEMOTO, H.; M. HAYASHI, F. ABE, T. NAKAMURA, M. ISHIZUKA & H. UMEZAWA: Immunosuppressive activities of 15-deoxyspergualin in animals. J. Antibiotics 40: 561-562, 1987
5. MAKINO, M.; M. FUJIWARA, H. WATANABE, T. AOYAGI & H. UMEZAWA: Immunosuppressive activities of deoxyspergualin. II. The effect on the antibody responses. Immunopharamcology 14: 115-122, 1987
6. YOSHIKAWA, Y.; H. UCHIDA, H. KURODA, T. NAKAMURA, A. OBAYASHI, A. FUJII & T. TAKEUCHI: In vivo effects of deoxyspergualin (NKT-01) on lymphocyte activation in response to alloantigens. J. Antibiotics 41: 1675-1680, 1988
7. NEMOTO, K.; K. HORIUCHI & T. MIYAMOTO: Deoxyspergualin is a new radioprotector in mice. Radiation Research 141: 223-226, 1995
8. LIEBMANN, J.; A. N. DELUCA, D. COFFIN, L. L. KEEFER, D. VENZON, D. A. WINK & J. B. MITCHELL: In vivo radiation by nitric oxide modulation. Cancer Research 54: 3365-3368, 1994
9. G-nitro-L-arginine. Cancer Research 54: 6458-6463, 1994
10. KUNIMOTO, S.; M. ISHIZUKA, H. IINUMA & T. TAKEUCHI: Basic studies on spergualins, in Gann Monograph on Cancer Research No. 36, "Antitumor natural products" Ed. T. TAKEUCHI, K. NITTA & N. TANAKA, pp. 179-191, Japan Scientific Societies Press, Tokyo, 1989
11. BAEUERLE, P. A. & T. HENKEL: Function and activation of NF-κB in the immune system. Annu. Rev. Immunology 12: 149-179, 1994
12. KUROSE, I.; S. MIURA, H. SAITO, S. TADA, D. FUKUMURA, H. HIGUCHI & H. ISHII: Rat Kupffer cell-derived nitric oxide modulates induction of lymphokine-activated killer cell. Gastroenterology 109: 1958-1968, 1995
13. HRABIE, J. A.; J. R. KLOSE, D. A. WINK & L. K. KEEFER: New nitric oxide-releasing zwitterions derived from polyamines. J. Organic Chemistry 58: 1472-1476, 1993 .
14. MARAGOS, C. A.; D. MORLEY, D. A. WINK, T. M. DUNAMS, J. E. SAAVEDRA, A. HOFFMAN, A. A. BOVE, L. ISAAC, J. A. HRABIE & L. K. KEEFER: Complexes of · NO with nucleophiles as agents for the controlled biological release of nitric oxide. Vasorelaxant effects. J. Medicinal Chemistry 34: 3242-3247, 1991
15. UMEZAWA, H.; S. KONDO, H. IINUMA, S. KUNIMOTO, Y. IKEDA, H. IWASAWA, D. IKEDA & T. TAKEUCHI: Structure of an antitumor antibiotic, spergualin. J. Antibiotics 34: 1622-1624, 1981
16. MISKO, T. S.; R. J. SCHELLING, D. SALVEMINI, W. M. MOORE & M. G. CURRIE: A fluorometric assay for the measurement of nitrite in biological samples. Analytical Biochemistry 214: 11-16, 1993
17. Analysis of Proteins, in Current Protocols in Molecular Biology Vol. 3, Eds. F. M. AUSUBEL, R. BRENT, R. E. KINGSTON, D. D. MOORE, J. G. SEIDMAN, J. A. SMITH & K. STRUHL, John Wiley & Sons, Inc., New York, 1996
18. AMEMIYA, H.: 15-Deoxyspergualin: a newly developed immunosuppressive agent and its mechanism of action and clinical effect: a review. Japan Collaborative transplant study group for NKT-01. Artif Organs 20: 832-835, 1996
19. OIKAWA, T.; M. SHIMAMURA, H. ASHINO-FUSE, T. IWAGUCHI, M. ISHIZUKA & T. TAKEUCHI: Inhibition of angiogenesis by 15-deoxyspergualin. J. Antibiotics 44: 1033-1035, 1991
20. KIUE, H.; T. ABE, A. MORIMOTO, K. OKAMURA, M. ONO, K. KHONO, T. OIKAWA, T. IWAGUCHI, M. ISHIZUKA, T. TAKEUCHI & M. KUWANO: Anti-angiogenic effect of 15-deoxyspergualin in angiogenesis model system involving human microvascular endothelial cell. Cancer J. 5: 267-271, 1992
21. NADLER, S. G.; M. A. TEPPER, B. SCHACTER & C. E. MAZZUCCO: Interaction of the immunosuppressant deoxyspergualin with a member of the Hsp70 family of heat shock proteins. Science 258: 484-486, 1992
22. NADEAU, K.; S. G. NADLER, M. SAULNIER, M. A. TEPPER & C. T. WALSH: Quantitation of the interaction the immunosuppressant deoxyspergualin and analogs with Hsc70 and Hsp90. Biochemistry 33: 2561-2567, 1994
23. NADLER, S. G.; C. B. ASHLEY, C. B. EVERSOLE, M. A. TEPPER & J. S. CLEAVELAND: Elucidating the mechanism of action of the immunosuppressant 15-deoxyspergualin. Therapeutic Drug Monitoring 17: 700-703, 1995
24. HOEGER, P. H.; M. A. TEPPER, A. FAITH, J. A. HIGGINS, J. R. LAMB & R. F. GEHA: Immunosuppressant deoxyspergualin inhibits antigen processing in monocytes. J. Immunology 153: 3908-3916, 1994
25. PEATTIE, D. A.; HARDING, M. W., FLEMING, M. A., DECENZO, M. T., LIPPKE, J. A., LIVINSTON, D. J. & BENASUTTI, M: Expression and characterization of human FKB52, an immunophilin that associates with the 90-kDa heat shock protein and is a component of steroid receptor complexes. Proc. Natl. Acad. Sci. USA 89: 10974-10978, 1992
26. YEM, A. W.; A. G. TOMASSELLI, R. L. HEINRIKSON, H. ZURCHER-NEELY, V. A. RUFF, R. A. JOHNSON & M. R. DEIBRL, Jr.: The Hsp56 component of steroid receptor complexes binds to immobilized FK506 and shows homology to FKBP-12 and FKBP-13. J. Biol. Chem. 267: 2868-2871, 1992
27. OWENS-GRILLO, J. K.; K. HOFFMANN, K. A. HUTCHISON, A. W. YEM, M. R. DEIBEL, Jr., R. E. HANDSCHUMACHER & W. B. PRATT: The cyclosporin A-binding immunophilin CyP-40 and the FK506-binding immunophilin hsp56 bind to a common site on hsp90 and exist in independent cytosolic hetero-complexes with the untransformed glucocorticoid receptor. J. Biol. Chem. 270: 20479-20484, 1995
28. OHINATA, A.: Biochemical mechanism of deoxyspergualin. In Deoxyspergualin: A new immunosuppressive agent. Ed. H. AMEMIYA, pp. 41-44 Nihon Igakukan, Inc., Tokyo, 1994 (in Japanese)
29. ORDAN, H.; Y. FUKUDA, S. SUZUKI, H. AMEMIYA & K. DOHI: Simultaneous evaluation of nitric oxide synthesis and tissue oxygenation in rat liver allograft rejection using near-infrared spectroscopy. Transplantation 60: 530-535, 1995
30. ROGERS, N. E. & L. J. IGNARRO: Constitutive nitric oxide synthase from cerebellum is reversibly inhibited by nitric oxide formed from L-arginine. Biochem. Biophys. Res. Commun. 189: 242-249, 1992
31. GRISCAVAGE, J. M.; N. E. ROGERS, M. P. SHERMAN & L. J. IGNARRO: Inducible nitric oxide synthase from a rat alveolar macrophage cell line is inhibited by nitric oxide. J. Immunology 151: 6329-6337, 1993